Neurocrine Biosciences (NBIX) Amortizatization of Intangibles (2010 - 2026)

Neurocrine Biosciences (NBIX) has reported Amortizatization of Intangibles for 17 consecutive years, with $900000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Amortizatization of Intangibles fell 87.32% year-over-year to $900000.0; the trailing twelve-month figure through Jun 2026 stood at $2.0 million (down 92.42% YoY), and the FY2025 full-year result was $12.7 million, down 51.53% from the prior year.
• Amortizatization of Intangibles eased to $900000.0 in Q2 2026 per NBIX's latest filing, from $2.7 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $7.2 million in Q1 2025 and bottomed at -$8.2 million in Q4 2025.
• Historically, Amortizatization of Intangibles has averaged $3.8 million across 5 years, with a median of $6.0 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles surged 270.27% in 2023, then plunged 246.43% in 2025.
• Over 5 years, Amortizatization of Intangibles stood at -$3.7 million in 2022, then soared by 270.27% to $6.3 million in 2023, then slipped by 11.11% to $5.6 million in 2024, then slumped by 246.43% to -$8.2 million in 2025, then soared by 110.98% to $900000.0 in 2026.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $900000.0, $2.7 million, and -$8.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.